Aptorum Group Ltd-Class A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.83

-0.02 (-1.77%)

As of May 16, 2:33 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,391.0% upside

Low Target $9.33

Average Target $12.39

High Target $15.15

Current Price $0.83

Current
$0.83

Target
$12.39

$9.33 $12.39 avg $15.15

Scenario Analysis

Bear Case

$9.33

1,022.7%

Low target

Base Case

$12.39

+1,391.0%

Avg target

Bull Case

$15.15

+1,723.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$4.47

-81.4% from high

52-Week Low

$0.65

+27.8% from low

Target vs 52W High

$12.39

+177.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%